LOS ANGELES--(BUSINESS WIRE)--Children with high-risk neuroblastoma can now access a specialized, targeted radiation treatment called MIBG therapy at Children’s Hospital Los Angeles—one of the largest ...
Children’s Hospital Los Angeles has begun offering a radiation drug therapy using metaiodobenzylguanidine, or MIGB, to children with high-risk neuroblastoma. Neuroblastoma is the second-most common ...
JACKSONVILLE, Fla. — Joia Suggs, a single mother of five, is navigating the challenges of caring for her son Joidon, who was diagnosed with neuroblastoma in 2023. Joidon, now five years old, has ...
Fifty-three patients with refractory or relapsed neuroblastoma were treated with 18 mCi/kg 131 I-MIBG on a phase I/II protocol. The median whole-body radiation dose was 2.92 Gy. These results ...
Approximately half of children with neuroblastoma - a childhood cancer that develops from immature nerve cells - have a form that indicates a high likelihood of recurrence. New findings published by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results